Emily Titus

Senior Vice President, Technical Operations • Notch Therapeutics

Emily obtained her PhD from the Institute of Biomaterials and Biomedical Engineering at the University of Toronto, where she used a combination of laboratory and bioinformatics approaches to define and interpret gene regulatory networks controlling embryonic stem cell fate decisions. At Notch, she oversees the Technical Operations function, which includes Process and Analytical Development, Manufacturing Sciences, Engineering and Project Management. Previously, she held the position of Vice President, Technology Advancement at CCRM, where she built cell reprogramming, genome engineering and pluripotent stem cell differentiation programs and led the company incubation program that culminated in the launch of Notch Therapeutics.


Also Speaking

Matthew Li

Director, Cell Therapy CMC • Tome Biosciences

David Chang

Chief Executive Officer • WuXi Advanced Therapies

Emma Bjorgum

Vice President, Client Services, DNA • Aldevron

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.